From the category archives:

Current Research

‘‘It’s Something I Need to Consider” Decisions About Carrier Screening for Fragile X Syndrome in a Population of Non-Pregnant Women – Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA. 2009 – Am J Med Genet Part A 149A:2731–2738

Download – PDF Format

{ Comments on this entry are closed }

Monash University Premutation (PM) study

Monash University are seeking to recruit individuals who carry the premutation (PM) for FXS. For more information, please contact Claudine Kraan on (03) 9902 4162 or claudine.kraan@monash.edu

Read the full article →

Clinical Trial in Adolescents with Fragile X

The Murdoch Childrens Research Institute is participating in a clinical trial testing a new treatment for Fragile X syndrome in adolescents. The treatment is a capsule and the medication is taken twice daily for up to 16 weeks. To be eligible to participate in the trial, patients must fit the following criteria: Be aged 12-17 [...]

Read the full article →

Clinical Trial in Adults with Fragile X

Fragile X Alliance Inc. and the Murdoch Childrens Research Institute are participating in a clinical trial testing a new treatment for Fragile X syndrome. The treatment is a capsule and the medication is taken twice daily for 12 weeks.  To be eligible to participate in the trial, patients must fit the following criteria: Be aged [...]

Read the full article →

Research into Carrier Screening

As a result of research into Carrier Screening, we have had a paper published in the American Journal of Medical Genetics ‘‘It’s Something I Need to Consider” Decisions About Carrier Screening for Fragile X Syndrome in a Population of Non-Pregnant Women – Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA. 2009 [...]

Read the full article →